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complex process which can induce depletion of aberrant or
infected cells and healing [1]. Successful healing of tissue injury
or infection requires that an immune response type is chosen,
which appropriately addresses the cause of inﬂammation. This
can be achieved by differential recruitment of distinct effector
cell types, notably of distinct T helper (Th) subsets, to the site
of inﬂammation by means of chemokine signals [2]. The various
T-cell subsets [3], such as Th1, Th2, Th17, and Treg cells, can serve
different immune functions, since they are characterised by
selective cytokine production and selective expression of chemo-
kine receptors. Recently, Th17 cells have drawn attention due to
their dual role in protection from microbial infection and chronic
inﬂammation and autoimmunity [4]. Indeed, an increasing num-
ber of reports indicate a role of Th17 cells in various liver diseases
and it has been suggested that interference with Th17 cell migra-
tion may be a potential therapeutic target [5]. Extending earlier
ﬁndings [6], Oo et al. now report that Th17 cells and IL17-
expressing CD8 T cells (Tc17) are present in a variety of liver dis-
eases at similar frequencies, predominantly in inﬂammatory inﬁl-
trates of portal tracts. Since it was not known how Th17 cells are
recruited to the inﬂamed liver, Oo et al. have now investigated
this issue.
In liver inﬂammation, the differential recruitment of Th sub-
sets is facilitated by chemokines that are expressed in dynamic
patterns by various liver cell types [2]. Although there is consid-
erable redundancy in chemokine signals [2], those chemokines
that signal through the chemokine receptor CXCR3 seem to be
of particular importance for lymphocyte recruitment to the
inﬂamed liver, notably of Th1 and Treg cells [7–9]. The chemo-
kine ligands of CXCR3, i.e., CXCL9, CXCL10, and CXCL11, are pro-
duced by many liver cells including hepatocytes, stellate cells,
and liver sinusoidal endothelial cells and are upregulated in var-
ious inﬂammatory liver diseases [2]. Oo et al. now show that
Th17 and Tc17 cells, like Th1 and Treg cells, are also recruitedJournal of Hepatology 20
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completely unexpected, since Th17 cells were known to express
CXCR3 [2]. Yet this ﬁnding suggests that there is little selectivity
in the initial recruitment of Th subsets to the liver. It seems that
CXCR3-dependent lymphocyte recruitment to the liver is a com-
mon mechanism of lymphocyte entry to the inﬂamed liver and
cannot serve differential recruitment of lymphocyte subsets.
Therefore, the question is how the observed non-selective
recruitment of different effector cell types could result in a tai-
lored inﬂammatory response that is able to adequately address
the cause of inﬂammation. One possibility is that strictly selec-
tive recruitment mechanisms are dispensable, since the inherent
plasticity of lymphocyte subsets, once within the liver, could
allow for a ﬂexible adaptation of the effector type [3]. Indeed,
it is known that Th subsets are not terminal differentiation
states and e.g., Th17 cells can express also signature cytokines
of Th1 cells, such as interferon-c or tumour necrosis factor-a
[3]. Oo et al. also ﬁnd Th17 cells in inﬂamed livers that partially
co-express interleukin-17 together with interferon-c, interleu-
kin-22 or tumour necrosis factor-a. However, it is not clear
how far the ﬂexibility of Th subsets actually goes, and whether
a change in the effector phenotype can occur in the inﬂamed
liver through local interactions with liver cells or other inﬂam-
matory cells. Thus far, there is no direct evidence that Th sub-
sets change their effector type during the course of liver
inﬂammation.
Another possibility to explain how non-selective recruitment
of different effector cell types could still guarantee an adequate
immune response type matching the cause of liver inﬂammation
is suggested by Oo et al. They argue that selectivity only occurs
after the initial non-selective CXCR3-mediated entry of lympho-
cytes into the liver, resulting in differential positioning and reten-
tion of different lymphocyte subtypes within the liver (Fig. 1).
Such positioning within the liver seems to be effected by second-
ary chemokine signals that are produced by activated stromal
cells, epithelial cells, and immune cells themselves [2]. It is
known, for example, that Th1 cells seem to migrate within the
liver under the inﬂuence of ligands for CCR5 and CXCR6 [2]. Oo
et al. now show that IL-17, which is produced by Th17 cells,
can selectively induce cholangiocytes to express CCL20. CCL20
is the ligand for CCR6, which is expressed by Th17 cells, and
thus can direct Th17 cells primarily to the portal tracts. This
recruitment of Th17 cells towards bile ducts could actually serve
the protection from bacterial and fungal infection of the liver12 vol. 57 j 943–945
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Fig. 1. Model of T cell recruitment to and positioning within the inﬂamed liver. Schematic representation, according to the paper by Oo et al., of the recruitment of Th1,
Th17, and Treg cells to the inﬂamed liver, which is initiated by CXCR3-mediated entry into the liver, and followed by selective positioning of T cell subsets within the liver
along chemokine gradients according to differentially expressed secondary chemokine receptors (only selected receptors are displayed).
Editorial[4], since bile ducts are potential entry sites for microbial
pathogens.
Th17 cells are not only protective in microbial infection, but
are also regarded as drivers of chronic and autoimmune
inﬂammation [4]. However, it is not clear whether Th17 cells
indeed drive liver inﬂammation or whether they rather swim
with the stream. Oo et al. ﬁnd that interleukin-17 producing
T cells are non-selectively recruited to the liver, and are pres-
ent in inﬂammatory liver inﬁltrates only at relatively low fre-
quencies (2–3% of CD3+ cells). These ﬁndings seem to
question a driver role of Th17 cells in liver inﬂammation. It
is possible that the composition of hepatic inﬂammatory inﬁl-
trates may reﬂect the expression of chemokine receptors, such
as CXCR3, by various immune cells. Consistent with that idea,
the intrahepatic levels of CXCR3 ligands have been reported
to correlate with the degree of liver inﬂammation [10]. The fre-
quency of Treg cells within the liver, which are recruited
through the CXCR3 axis [8], also seems to correlate with the
degree of inﬂammation [11]. Likewise, it is conceivable that
CXCR3-mediated Th17 recruitment to the inﬂamed liver may
also correlate with the degree of liver inﬂammation. Indepen-
dently of whether Th17 cells actually drive inﬂammation, there
is accumulating evidence that the presence of Th17 cells in the
inﬂamed liver may have a pathogenic role. Indeed, a patho-
genic function of IL-17 has been described in hepatic granu-
loma formation [12], in exacerbating liver ﬁbrosis [13], and
in hepatic tumour promotion [14]. However, it has also been
shown that IL-22 produced by Th17 cells can be hepatoprotec-
tive [15]. Thus, interference with IL-17 function could poten-
tially serve the therapeutic intervention in various liver
diseases; however, it remains to be seen whether interference
with Th17 cell migration within the liver is suitable for the
treatment of hepatic disease.944 Journal of Hepatology 201Conﬂict of interest
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